Latest Urology News
Cabozantinib did not increase survival of heavily treated patients with mCRPC, compared with prednisone.
Research emphasizes the need for nationwide refinements in the prostate cancer screening process.
In a small study, some men whose cancer progressed while on enzalutamide had a profound PSA response to pembrolizumab.
Findings in patients treated for T1a renal cell carcinoma followed with X-ray surveillance.
Adjusted odds ratio of prostate cancer significantly higher for MRI score than PSA.
Assay could cut down on cystoscopies, researchers say.
Largest Asian series to date shows a 5-year biochemical recurrence-free survival rate of 76.4%.
A majority of doctors and nurses reported wearing surgical masks as a precaution.
Swedish researchers say their findings are more useful for counseling men with a family history of prostate cancer.
Study results strengthen researchers' arguments for further clinical trials evaluating the potential protective effect of statins.
Imaging studies should be considered for men who have long symptom duration and voiding disturbances associated with acute prostatitis, researchers say.
Combination therapies targeting both mutations in the PI3K pathway and HER2 or hormone receptor overexpression should be evaluated, researchers say.
Second cancer was fatal in 55% of the cases studied.
Preliminary findings suggest a field effect in prostate cancer.
Low testosterone levels may be a contributing factor.
Urologists in Australia less favorable toward adjuvant radiotherapy in 2015 vs 2012.
Odds of using this strategy are 2.7-fold greater vs community facilities.
Genetic testing results could help guide therapy for advanced prostate cancer.
Being divorced or having never married also identified as risk factors.
Severe to profound hearing loss seen in 18% of male germ cell tumor survivors.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)